Form 8-K - Current report:
SEC Accession No. 0001104659-26-080562
Filing Date
2026-07-06
Accepted
2026-07-06 07:00:40
Documents
11
Period of Report
2026-07-06
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2619682d1_8k.htm   iXBRL 8-K 28567
  Complete submission text file 0001104659-26-080562.txt   193353

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA regn-20260706.xsd EX-101.SCH 3017
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE regn-20260706_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE regn-20260706_pre.xml EX-101.PRE 22360
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2619682d1_8k_htm.xml XML 3121
Mailing Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Business Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 9148477000
REGENERON PHARMACEUTICALS, INC. (Filer) CIK: 0000872589 (see all company filings)

EIN.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19034 | Film No.: 261154230
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)